Horizon 2020: How can European research and innovation effectively respond to societal challenges?

Flora Boyd

Remind me Printer-friendly version

Date

14 May 2012 22:00

Address

European Parliament

Brussels

Belgium

Links

Event's webpage

Event Type

M - Seminar, presentation

Section

Innovation & Enterprise

Event Location

Brussels

Related Events

28 Nov 2012 to 29 Nov 2012

European Gender Summit

The 2012 European Gender Summit will join the excellence and equality agendas in science, as a strategic approach for enhancing full realization of the research and innovation potential in Europe.

28 Nov 2012 to 29 Nov 2012

Sharing knowledge to build a stronger European economy driven by human capital

EVTA Ecosystem Conference: "Sharing knowledge to build a stronger European economy driven by human capital" 29-30 November 2012, Museum of Natural Sciences, Brussels.

14 Nov 2012

Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy

Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.

04 Nov 2012 to 05 Nov 2012

Enterprise Forum (London)'s Brussels visit

Monday 5 November 2012 (day 1)

15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels

25 Oct 2012

Financing PPP schemes - Choices, challenges and opportunities

10 Oct 2012

EuroCommerce SME Day

SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.

08 Oct 2012 to 09 Oct 2012

European Innovation Summit

COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.

06 Sep 2012

4th European Innovation Summit

Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.

05 Sep 2012

Financing and biopiracy: The challenges of the next UN Biodiversity Summit (COP11, India)

Biodiversity represents our most valuable natural heritage and its conservation is one of our most urgent challenges. Beyond its immaterial value, biodiversity plays a vital role for human beings.

04 Jul 2012 to 05 Jul 2012

Delivering better SME and Enterprise support through EU Programmes and Policies

20 Jun 2012 to 21 Jun 2012

FP7 Project Management and Audits - Practical workshop to help ensure successful implementation of your FP7 projects and survive EC audits

FP7 - Project Management and Audits in Brussels

21-22 June 2012

The FP7 - Project Management and Audits course will help ensure successful implementation of your FP7 projects and survive EC audits.

12 Jun 2012

EVIA General Assembly 2012

Annual General Meeting -12 June from 11.00 to 13.00 followed by a lunch

“The Importance of Indoor Air Quality - An Area for Future Regulation”

07 Jun 2012

EU's Research and Innovation ecosystem: what's in it for SMEs?

REGISTER NOW FOR THE EVENT

29 May 2012 to 30 May 2012

Meeting of Competitiveness Council (COMPET)

The EU ministers responsible for the single market, industry and research usually meet four times annually in the Competitiveness Council. The council is responsible for further developing the EU’s single market and ensuring the framework conditions for European industry and research.

25 Apr 2012

European Business Summit

2012 Theme: 'Skills for Growth'

13 Apr 2012

Discussion Forum ¨Market Size and Innovation in the Pharmaceutical Industry"

An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.